The short answer
California listed glyphosate under Prop 65 in 2017 based on IARC's classification. But federal courts blocked enforcement of the cancer warning, ruling it could be false or misleading given other agencies' findings. It's a striking clash between hazard-based listing and disputed science.
Glyphosate was listed under Prop 65 in 2017 via the IARC-linked route.
IARC calls glyphosate 'probably carcinogenic'; the EPA disagrees.
Federal courts blocked enforcement of the warning on First Amendment grounds.
Courts found a required cancer warning could be false or misleading here.
Choose how you want to understand this
The full explanation.
When agencies disagree, courts get involved
The story of glyphosate and Proposition 65 is where the hazard-versus-risk debate stops being academic and lands in federal court.
Glyphosate is the world's most widely used weedkiller. In 2015, the International Agency for Research on Cancer classified it as "probably carcinogenic to humans" (Group 2A). Through California's IARC-linked listing route, that classification triggered a Prop 65 listing, effective 2017. Listing meant sellers could be required to warn that glyphosate is "known to the State of California to cause cancer."
The scientific disagreement underneath
But there was a problem: other major agencies disagreed with IARC. The U.S. EPA concluded that glyphosate is "not likely to be carcinogenic to humans" at expected exposures. The European Food Safety Authority reached a similar view. As our page on glyphosate explains, this is a genuine, unresolved scientific dispute — and a textbook example of IARC judging hazard while the EPA judged risk.
So California's law was poised to require a warning stating, flatly, that glyphosate is known to cause cancer — even though the EPA had concluded the opposite.
The First Amendment challenge
Agricultural groups (led by the National Association of Wheat Growers) sued. Their argument was not primarily about the science but about compelled speech: the government cannot force a business to state a controversial claim as settled fact. Requiring sellers to warn that glyphosate is "known to cause cancer," they argued, was false or misleading given the weight of scientific opinion, and thus violated the First Amendment.
Federal courts agreed. They blocked enforcement of the glyphosate cancer-warning requirement, finding that the mandated language was misleading and could not be compelled. Later rulings, including at the appeals level, upheld this reasoning.
What the case reveals
The glyphosate battle is important beyond glyphosate itself:
- It shows what happens when a hazard-based listing (IARC's) collides with a risk-based conclusion (the EPA's) — the conflict can end up in court.
- It illustrates a limit on Prop 65: a warning can be legally blocked if forcing it would state disputed science as certainty.
- It underscores that "known to cause cancer" on a label is a strong claim — and courts scrutinize whether it's accurate.
The bottom line
California listed glyphosate under Prop 65 based on IARC's hazard classification, but federal courts blocked the cancer warning on free-speech grounds, finding it could be false or misleading given other agencies' conclusions. Whatever one thinks of glyphosate's risks, the case is a vivid reminder that hazard classifications and real-world risk conclusions can diverge — sometimes sharply enough to require a judge to sort out.
Words to know
Tap any term to see what it means.
Common questions
▸Why was glyphosate listed under Prop 65?
Because IARC classified it as 'probably carcinogenic to humans' in 2015, which triggered listing through California's IARC-linked (Labor Code) mechanism, effective 2017.
▸Why did courts block the warning?
Groups challenged the required warning on First Amendment grounds, arguing that forcing sellers to state glyphosate is 'known to cause cancer' was misleading given that the EPA and others concluded it is not likely carcinogenic. Courts agreed the mandated warning could be false or misleading.
▸Is glyphosate still on the Prop 65 list?
The listing has been the subject of ongoing litigation, but courts have blocked enforcement of the cancer-warning requirement. As a result, the warning is not being enforced.
▸What does this dispute show?
It highlights the tension when a hazard-based listing (IARC's) conflicts with other agencies' risk-based conclusions (the EPA's), and how that conflict can play out in court.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 4 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.